4//SEC Filing
Reeve Emma 4
Accession 0001680329-25-000014
CIK 0001070081other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 5:20 PM ET
Size
8.7 KB
Accession
0001680329-25-000014
Insider Transaction Report
Form 4
Reeve Emma
Director
Transactions
- Exercise/Conversion
Common Stock
2025-12-03$46.54/sh+733$34,114→ 7,399 total - Sale
Common Stock
2025-12-03$78.62/sh−733$57,628→ 6,666 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-03−733→ 734 totalExercise: $46.54Exp: 2035-01-02→ Common Stock (733 underlying)
Footnotes (2)
- [F1]This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2025.
- [F2]This option was granted on January 3, 2025 and vests over one year in twelve equal monthly installments, commencing on February 3, 2025.
Documents
Issuer
PTC THERAPEUTICS, INC.
CIK 0001070081
Entity typeother
Related Parties
1- filerCIK 0001680329
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 5:20 PM ET
- Size
- 8.7 KB